A detailed history of Cassady Schiller Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 2,609 shares of ABBV stock, worth $457,018. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,609
Previous 2,942 11.32%
Holding current value
$457,018
Previous $504,000 2.18%
% of portfolio
0.2%
Previous 0.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $54,558 - $66,376
-333 Reduced 11.32%
2,609 $515,000
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $5,727 - $6,688
-37 Reduced 1.24%
2,942 $504,000
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $9,429 - $10,743
59 Added 2.02%
2,979 $542,000
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $17,888 - $20,146
-130 Reduced 4.26%
2,920 $452,000
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $23,645 - $27,373
177 Added 6.16%
3,050 $454,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $44,125 - $54,911
333 Added 13.11%
2,873 $387,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $80,981 - $93,262
-560 Reduced 18.06%
2,540 $404,000
Q4 2022

May 16, 2023

BUY
$138.31 - $165.87 $6,362 - $7,630
46 Added 1.81%
2,586 $418,000
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $13,001 - $15,591
94 Added 3.13%
3,100 $501,000
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $39,994 - $45,871
298 Added 11.0%
3,006 $403,000
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $4,954 - $6,298
36 Added 1.35%
2,708 $415,000
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $175,533 - $217,787
1,330 Added 99.11%
2,672 $433,000
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $144,171 - $182,418
1,342 New
1,342 $182,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cassady Schiller Wealth Management, LLC Portfolio

Follow Cassady Schiller Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cassady Schiller Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cassady Schiller Wealth Management, LLC with notifications on news.